Factsheets and Policy and Programmatic Recommendations – Evidence-Informed Technical Advocacy for HPV Vaccine Introduction in Nigeria

Cervical cancer remains one of the leading causes of cancer deaths among women in Nigeria—yet it is largely preventable and treatable. Because HPV causes approximately 95% of cervical cancer cases, sustained HPV vaccination, alongside screening and treatment, is central to prevention.

Through the Evidence-Informed Technical Advocacy project, MSH and partners conducted research across Kano, Kaduna, and Lagos States to identify opportunities and challenges in sustaining HPV vaccine delivery. The analysis estimated that vaccinating each eligible girl costs between ₦9,000 and ₦14,000 (approximately USD $6-$9) and highlighted the need for state-level policies, dedicated budget lines, and stronger coordination mechanisms to ensure continuity beyond Gavi support.

Driving Sustainable Solutions

Stakeholders discussed policy, financing and coordination priorities to guide next steps:

• Policy Reform: Align national and state frameworks, expand vaccination to all girls aged 9–14, and explore school-based HPV certification requirements.
• Financing: Establish clear budget lines, leverage the Basic Health Care Provision Fund, and develop state-level basket funds to ensure consistent funding for routine immunization.
• Coordination: Strengthen the Technical Working Groups (TWGs), revitalize scorecards, and embed HPV activities into annual operational plans for accountability and ownership.

Kano State’s remarkable increase in HPV vaccination coverage, from 4% to 86%, was highlighted as a model of local leadership, government ownership, and partner coordination.

Participants emphasized that sustainable HPV vaccination requires a multisectoral approach, community trust, and strong local leadership. Partners reaffirmed their shared commitment to ensuring that every Nigerian girl—whether in or out of school—has access to this life-saving vaccine.

Resources available for download: 

• Kaduna State – HPV Vaccination Factsheet
• Kaduna State – Policy and Programmatic Recommendations for Sustained Human Papillomavirus (HPV) Vaccination Delivery
• Kano State – HPV Vaccination Factsheet
• Kano State – Policy and Programmatic Recommendations for Sustained Human Papillomavirus (HPV) Vaccination Delivery
• Lagos State – HPV Vaccination Factsheet
• Lagos State – Policy and Programmatic Recommendations for Sustained Human Papillomavirus (HPV) Vaccination Delivery
• National Consolidated Policy and Programmatic Recommendations for Sustained Human Papillomavirus (HPV) Vaccination Delivery in Kaduna, Kano and Lagos States